StockDrifts LogoStockDrifts

Duchem Bio 176750

Company
듀켐바이오Duchem Bio
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2024-06-14

Duchem Bio (176750) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Duchem Bio is dated 2023-03-29; the most recent is 2024-06-14.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2024-06-14SELL시간외매매
김종우
Jongwoo Kim
vice president-362.0K₩9,350-24.9%₩3.4B ($2.4M)
2024-06-14BUY시간외매매
지오영
Geoyoung
-362.0K₩9,350+24.9%₩3.4B ($2.4M)
2023-03-29BUY주식매수선택권
김봉석
Kim Bong-seok
Managing Director25.0K₩6,380+83.1%₩160M ($111K)

Frequently asked questions

Who has been buying Duchem Bio stock?
0 distinct insiders have filed 0 disclosed insider purchases in Duchem Bio (176750), most recently on 2024-06-14. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Duchem Bio have?
Duchem Bio has 0 buy-side and 0 sell-side disclosures on record, spanning 2023-03-29 to 2024-06-14.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.